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Assembly of the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein on budding virus
particles is important for efficient infection of target cells. In infected cells, lipid rafts have been proposed to
form platforms for virus assembly and budding. Gag precursors partly associate with detergent-resistant
membranes (DRMs) that are believed to represent lipid rafts. The cytoplasmic domain of the envelope gp41
usually carries palmitate groups that were also reported to confer DRM association. Gag precursors confer
budding and carry envelope glycoproteins onto virions via specific Gag-envelope interactions. Thus, specific
mutations in both the matrix domain of the Gag precursor and gp41 cytoplasmic domain abrogate envelope
incorporation onto virions. Here, we show that HIV-1 envelope association with DRMs is directly influenced by
its interaction with Gag. Thus, in the absence of Gag, envelope fails to associate with DRMs. A mutation in the
p17 matrix (L30E) domain in Gag (Gag L30E) that abrogates envelope incorporation onto virions also
eliminated envelope association with DRMs in 293T cells and in the T-cell line, MOLT 4. These observations
are consistent with a requirement for an Env-Gag interaction for raft association and subsequent assembly
onto virions. In addition to this observation, we found that mutations in the gp41 cytoplasmic domain that
abrogated envelope incorporation onto virions and impaired infectivity of cell-free virus also eliminated
envelope association with DRMs. On the basis of these observations, we propose that Gag-envelope interaction
is essential for efficient envelope association with DRMs, which in turn is essential for envelope budding and
assembly onto virus particles.
Lipid rafts are tightly packed liquid-ordered microdomains
enriched in cholesterol, sphingolipids, and glycerophospholip-
ids. The existence of lipid rafts on cell membranes is contro-
versial. Lipid rafts have been defined biochemically as mem-
branes that are resistant to detergent at low temperature (41)
and are frequently described as detergent-resistant membranes
(DRMs) (5, 6, 40). DRMs can be separated by ultracentrifu-
gation of detergent-lysed cells in sucrose gradients. It is possi-
ble that such methods of isolation may affect cell structure and
create lipid rafts as an artifactual phenomenon (reviewed in
reference 40). Nevertheless, the association of particular mem-
brane proteins with DRMs has frequently been shown to have
strong physiological relevance. Thus, lipid rafts have been im-
plicated as platforms for signal transduction and cell activation
(39), and it has been suggested that they are involved in the
traffic and sorting of membrane proteins at sites throughout
the cell, including the endoplasmic reticulum, Golgi complex,
cell membrane, and vesicles (24, 30, 31, 39). Rafts may also act
as platforms for budding and assembly of enveloped viruses
(41, 43). The glycoproteins of several enveloped viruses, such
as influenza virus (46), Rous sarcoma virus (32), murine leu-
kemia virus (25), measles virus (27), Ebola virus (2), and hu-
man (HIV) and simian (SIV) immunodeficiency virus (4, 38,
45) have been shown to associate with DRMs. As a result,
there is now much attention focused on the importance of lipid
rafts as a docking site for the assembly of many enveloped
viruses.
The assembly and incorporation of human immunodefi-
ciency virus type 1 (HIV-1) envelope glycoproteins onto virions
have been shown to be regulated by a stable interaction be-
tween the matrix domain of the p55gag precursor and envelope
(gp41) cytoplasmic domain (12–16, 21). The matrix domain is
myristoylated, and this fatty acid group targets the p55 precur-
sor to membranes (17, 22, 33, 35) and rafts (34). The envelopes
of HIV-1, HIV-2, and SIVs carry cysteine residues in the cy-
toplasmic domains that are palmitoylated and also reported to
promote association with rafts and assembly onto budding
virions (4, 38, 45). In HIV-1, two relatively conserved cysteine
residues occur at the envelope positions 764 and 837. We
previously confirmed that these gp41 cytoplasmic-domain cys-
teines are important for HIV-1 envelope association with lipid
rafts. Nevertheless, nearly wild-type (wt) levels of infectivity
are retained if C764 and C837 are both substituted by amino
acids with bulky hydrophobic side chains (4). The latter enve-
lopes failed to associate with light lipid rafts (DRM-L) but
retain association with heavier DRM-H (heavy lipid raft) frac-
tions. In contrast, substitution of C764/C837 by alanine resi-
dues eliminated envelope association with rafts and decreased
infectivity by over 60%. In contrast, Chan et al. reported that
the same gp41 mutations failed to affect envelope association
with DRMs (8).
Our previous study was carried out in 293T cells transfected
with vectors that encode envelope and all other viral proteins
(4). Here, we investigated the roles of other HIV proteins,
including Gag in the recruitment of HIV-1 envelope glycopro-
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teins to DRMs and subsequent envelope assembly onto newly
synthesized virions. Our results demonstrate that Gag recruits
envelope to DRMs, thus facilitating the assembly of envelope
glycoproteins onto budding virions.
MATERIALS AND METHODS
Reagents and antibodies. -Methyl cyclodextrin, protease inhibitor cocktail,
and EGTA were obtained from Sigma Chemical Co., St. Louis, MO. X-Gal
(5-bromo-4-chloro-3-indolyl--D-galactopyranoside) was from Fisher Bio-re-
agents, Inc. Anti-mouse F(ab)2 fragment conjugated to -galactosidase was
from Southern Biotechnology, Inc. Polyclonal anti-rabbit caveolin was obtained
from BD Transduction Laboratory, Inc. Monoclonal antibodies (MAbs) to gp41,
Chessie 8 (9), and 183-H12-5C (42) to p55gag were provided by the U.S. NIH
AIDS Research and Reference Program. Hybridoma supernatant containing p24
MAbs 38:96K and EF7 were provided by the Centralized Facility for AIDS
Reagents, Potters Bar, United Kingdom.
Plasmids and molecular constructs. HIV-1 molecular clones pNL4.3 and
pHXB2 were described previously (3, 37). pSV2tat72 (11) was obtained from the
U.S. NIH Reagents and Reference Program. gp160 envelope fragments were
cloned into KpnI sites in the pSVIIIenv vector (36). The LN40 and B33 envelope
sequences were amplified from lymph node (LN) and brain autopsy tissue,
respectively, of patient NA420 as described previously (36). The L30E substitu-
tion in p17 matrix of env pNL4.3 molecular clone was prepared by PCR. The
pNL4.3 L30E clone was provided by Eric Freed (National Cancer Institute,
NCI-Frederick). Point mutations in NA420 LN40 gp41 cytoplasmic domains
were introduced by PCR.
Cell culture and transfection. Human embryonic kidney (293T) cells, CD4
CXCR4 and CD4 CCR5 GHOST and NP2 cells were maintained in Dul-
becco’s modified Eagle’s medium with 4% fetal bovine serum (FBS). pSVIIIenv
constructs were cotransfected with env pNL4.3 into 293T cells using calcium
phosphate precipitation method (Promega, Inc.). Progeny pseudovirions were
harvested at 48 h, clarified by centrifugation (1,000  g for 10 min), aliquoted,
and stored at 152°C.
Cell-cell fusion. Cell-cell fusion was tested by cocultivating 293T cells cotrans-
fected with env pSVIIIenv and env pNL4.3 with target cells that expressed
CD4 and appropriate coreceptors. GHOST or NP2 cells were seeded at 2  104
cells per well in 48-well tissue culture dishes. Fifteen to 18 h posttransfection, 5 
105 Env 293T cells were cocultivated with an equal amount of appropriate
CD4, coreceptor-positive target cells. After 6 to 8 h of incubation, cells were
washed in phosphate-buffered saline (PBS) and fixed for 10 min with methanol
containing 1% methylene blue and 0.25% basic fuchsin. Fixed cells were
destained within PBS and examined for syncytium formation by microscopy.
Preparation of VSV-G HIV-1 particles. A vesicular stomatitis virus VSV-G
expression vector was cotransfected with either pNL4.3 wt or pNL4.3 L30E into
293T cells using calcium phosphate precipitation method (Promega, Inc.). Prog-
eny pseudovirions were harvested at 48 h, clarified by centrifugation (1,000  g
for 10 min), aliquoted, and stored at 152°C.
Infectivity assay, p24 immunostaining, and RT ELISA. CD4, CXCR4, or
CCR5 GHOST and NP2 cells were infected with serial dilutions of pseudo-
viruses in duplicate. VSV-G pseudovirions were titrated onto HeLa cells that
lacked CD4. Infected cells were washed 72 h postinfection with PBS and fixed in
cold (20°C) methanol-acetone (1:1) for 10 min. Cells were washed once with
PBS and then with PBS containing 1% FBS (PBS–1% FBS) before adding
anti-HIV p24 monoclonal antibodies (38:96K and EF7) as hybridoma cell culture
fluid (1:40) in PBS–1% FBS. After 1 h, cells were washed with PBS–1% FBS and
incubated for 1 hour with anti-mouse -galactosidase (1:400) in PBS–1% FBS.
Cells were washed once with PBS–1% FBS and twice with PBS and stained with
the addition of X-Gal substrate (0.5 mg/ml of 5-bromo-4 chloro-3-indolyl--D-
galactopyranoside in PBS containing 3 mM potassium ferricyanide, 3 mM po-
tassium ferrocyanide, and 1 mM magnesium chloride). The resultant blue-
stained cells were regarded as foci of infection, and the virus infectivity was
estimated as focus-forming units (FFU) per ml. The reverse transcriptase (RT)
activity of cell-free viruses was estimated by RT–enzyme-linked immunosorbent
assay (ELISA) (CavidiTech, Inc., Uppsala, Sweden). Infectivity titers were ex-
pressed as FFU/RT activity.
Isolation of detergent-resistant membranes and sucrose density centrifuga-
tion. gp160 expressing 293T or MOLT 4 cells were lysed with Triton X-100 at a
final concentration of 0.5% in TNE buffer (10 mM Tris [pH 7.5], 100 mM sodium
chloride, and 10 mM EGTA) supplemented with protease inhibitor cocktail for
30 min on ice. Cellular lysates were homogenized and centrifuged at low speed
to remove nuclei. Supernatants were adjusted to 60% sucrose in 1-ml volume and
loaded on top of 250 l of 80% sucrose. Subsequent sucrose gradients of 50%,
40%, 35%, 10%, and 5%, respectively, were layered on top to a final volume of
5 ml. These steps were carried out on ice. Sucrose gradients were centrifuged at
100,000  g for 18 h at 4°C in a SW 50.1 Ti rotor (Beckman, Inc.). Fourteen
fractions were collected from the top, and each fraction was immunoprecipitated
with HIV-positive human serum (1:1,000). Immunoprecipitated samples were
analyzed for envelope (gp160 and gp41) and p55 by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) followed by Western blotting,
using monoclonal antibodies Chessie 8 and 183-H12-5C to probe envelope and
p55gag, respectively. The density of each fraction was quantified using a refrac-
tometer.
Western blotting and cell lysis. The efficiency of envelope expression was
assessed by Western blotting. Env cells were lysed in 1% Triton X-100 supple-
mented with protease inhibitor cocktail and homogenized with a 30-gauge sy-
ringe needle (three times). Debris was removed by microcentrifugation. Lysate
supernatants were resolved by SDS-PAGE before blotting and probing for
gp160/gp41 with MAb Chessie 8 and for p24 with MAb 183-H12-5C.
Envelope incorporation onto virus particles. To investigate envelope incorpo-
ration onto virus particles, 293T cells were cotransfected with env pSVIIIenv
constructs together with env pNL4.3. Env pseudotype viruses were harvested
at 48 h, centrifuged at low speed, and passed through 0.45-m-pore-size syringe
filters to remove cell debris. Virus particles were pelleted at 100, 000  g for 2 h
at 4°C, and pellets were reconstituted in PBS. The RT activity of each pellet was
measured by RT-ELISA, and equal amounts of RT activity were then resolved
by SDS-PAGE before blotting and probing for gp160/gp41 with MAb Chessie 8
and for p24 with MAb 183-H12-5C.
RESULTS
Envelope association with lipid rafts is eliminated in the
absence of the Gag precursor. We first investigated whether
HIV-1 envelope required other viral proteins to associate with
DRMs. Envelope was expressed from pSVIIIenv, which en-
codes envelope and Rev but also requires Tat for efficient
envelope expression. 293T cells were therefore cotransfected
with pSVIIIenv (NL4.3 envelope) with either env pNL4.3
(encodes all HIV-1 proteins except envelope) or the Tat ex-
pression vector pSV2tat72. We examined envelope expression
in the transfected 293T cells by immunostaining with Chessie 8,
an anti-gp41 MAb. As shown in Fig. 1A (top row of micro-
graphs), envelope expression was detected for both cotransfec-
tions. Envelope expression via each cotransfection also con-
ferred equivalent levels of cell-cell fusion GHOST/CXCR4
cells (Fig. 1A, bottom row of micrographs). Envelope expres-
sion was also evaluated by Western blotting of cell lysates.
Slightly larger amounts of envelope were detected for cotrans-
fections of pSVIIIenv and Env pNL4.3 compared to cotrans-
fections with pSVIIIenv and pSV2tat72 (Fig. 1A, blot). We
next tested envelope association with DRMs using flotation
gradient centrifugation as described in Materials and Methods.
Thus, transfected env 293T cells were lysed with Triton X-100
to a final concentration of 0.5% in TNE buffer at 4°C. Subse-
quently, postnuclear supernatant contents were fractionated by
sucrose density gradient centrifugation, and each fraction was
analyzed for envelope content. As shown in Fig. 1B, in the
absence of viral proteins other than Tat and Rev, envelope was
excluded from the classical raft fractions (DRM) with most of
envelope present in the detergent-sensitive membrane (DSM)
fraction. When all other viral proteins were present, envelope
was clearly detected in DRM-L and to some extent in DRM-H
fractions. Densitometry measurements revealed that 96% of
gp160 was present in the DSM fractions when envelope was
expressed with just Tat and Rev. However, 19.4% of gp160 was
present in DRM-L and 12% in DRM-H when all other viral
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proteins were present. These observations are similar to those
of our previous report (4). Most HIV-1 strains have two cys-
teine residues in the gp41 cytoplasmic domain at positions 764
and 837 that are targets for palmitoylation (45). However,
NL4.3 contains only one cysteine residue at residue 764. We
therefore also tested the HXB2 envelope that has both cys-
teine residues. Figure 1B shows that in the absence of viral
proteins other than Tat and Rev, HXB2 envelope also failed to
associate with DRM with 96% of gp160 present in the DSM
fractions. This result confirmed that envelope was unable to
associate with lipid rafts without the cooperation of one or
more viral proteins.
A matrix mutation that abrogates envelope incorporation
onto virions disrupts envelope assembly in lipid rafts. Since it
has been reported that the envelope interacts directly with the
matrix domain of the p55gag precursor, we next investigated the
role of Gag in envelope association with DRMs. A single
specific amino acid substitution in the matrix (p17) domain of
the Gag protein was previously shown to eliminate envelope
incorporation onto virus particles (16). The L30E substitution
was therefore introduced into the matrix domain of the env
pNL4.3 construct to create pNL4.3 (L30E) env. pSVIIIenv
(NL4.3 envelope) was cotransfected with env pNL4.3 (L30E)
in 293T cells, and pseudotype viruses were harvested. Immu-
nostaining of the transfected 293T cells with MAb Chessie 8
(Fig. 2A, left panels) and cell-cell fusion assays (Fig. 2A, right
panels) confirmed that the envelope protein was expressed and
functional for fusion. Similar levels of envelope expression
after cotransfection with either Env pNL4.3 wt or L30E, were
also indicated by Western blotting of transfected cell lysates
(data not shown). Harvested viruses were titrated on CD4
CXCR4 GHOST and NP2 cells to evaluate their infectivity
and also subjected to Western blot analysis to assess the
amount of envelope incorporated onto virions. As expected,
the matrix mutation resulted in over 95-fold reduction in in-
fectivity (Fig. 2B) and dramatic reduction in the amount of
envelope incorporation onto virions (Fig. 2C).
We next evaluated the effect of the L30E matrix mutation on
envelope association with DRMs. 293T cells were cotrans-
fected with pSVIIIenv with either the env pNL4.3 or env
pNL4.3 (L30E) construct. Env 293T cells were washed, lysed,
and processed for sucrose density gradient centrifugation as
described above. When expressed in conjunction with a Gag
L30E protein, envelope proteins were absent from DRM frac-
tions, with96% of gp160 in the DSM fractions and only trace
amounts in DRM-H fractions (Fig. 3). In contrast, when wt
Gag was present, substantial amounts of envelope (37% of
gp160) were found in DRM-L. However, the L30E mutation
had no effect on Gag (p55) association with raft fractions. In a
final confirmatory experiment, pSVIIIenv and pSV2tat72 were
cotransfected with and without pCMV-p55 that expresses only
Gag. Again, envelope associated with DRMs only if Gag was
expressed (data not shown). Together, these results show that
envelope association with DRM-L is dependent on Gag.
Gag is required for envelope to associate with DRMs in
MOLT 4 T-cells. The experiments described above were all
based on the analysis of the human embryonic kidney 293T cell
line. To evaluate whether the observations made were relevant
for HIV replication in T cells, the role of Gag in envelope
association with DRMs was investigated in the MOLT 4 T-cell
line. Pseudovirions carrying the VSV-G glycoprotein were first
prepared by cotransfecting 293T cells with pVSV-G and either
pNL4.3 or pNL4.3 L30E full-length clone. MOLT 4 cells were
then infected with VSV-G NL4.3 or VSV-G NL4.3 L30E
virus at a multiplicity of infection of 1. After 72 h, cells were
lysed with Triton X-100 at 4°C and analyzed by sucrose density
gradient centrifugation as described in Materials and Methods.
Envelope was associated with DRMs only in the presence of wt
Gag (28% in DRM-L and 19% in DRM-H) and located only
in the soluble fraction (90%) when expressed with the mu-
tated Gag L30E (Fig. 4). Thus, envelope association with
DRMs required a functional Gag precursor in T cells as well as
in 293T cells.
Do buoyant Gag particles affect envelope location in sucrose
gradients? Gag particles are themselves buoyant (20, 26), and
it was possible that such particles float up in sucrose gradients
carrying envelope with them independently of DRM associa-
tion. HIV virions have a buoyant density of about 1.15 g/ml in
sucrose gradients (7). This density is at the highest end of the
densities of DRM-L fractions (1.09 to 1.15 g/ml). The majority
of buoyant envelope detected in DRM-L here conferred a
range of densities generally lower than 1.15 g/ml. Treatment of
293T cells with 10 mM of -methyl cyclodextrin to disrupt
DRMs eliminated Gag from the DRM-L fractions but did not
affect Gag association within the fractions that represent
heavier rafts (DRM-H at 1.16 to 1.2 g/ml). The Gag in these
fractions may thus contain buoyant Gag complexes as de-
scribed by Lindwasser and Resh (26) and Holm et al. (20).
Despite the presence of Gag in fractions associated with
DRM-H, envelope was completely removed from all DRM-L
FIG. 1. Roles of viral proteins on HIV-1 envelope association with rafts. (A) Envelope expression and fusigenicity in the presence and absence
of other viral proteins. 293T cells were cotransfected with pSVIIIenv (NL4.3 env) with either env pNL4.3 or pSV2tat72 and were immunostained
for envelope. Cells were fixed and permeabilized with methanol-acetone (1:1) 48 h after transfection before immunostaining with anti-gp41 MAb
Chessie 8 (top row of micrographs). Cell-cell fusion and syncytium induction were detected by cocultivation of 293T cells expressing NL4.3
envelopes in the presence and absence of env pNL4.3 with GHOST/CXCR4 cells. Cells were fixed and stained with 1% methylene blue and 0.25%
basic fuchsin in methanol (bottom row of micrographs). Western blot of 293T cell lysate taken 48 h after transfection with pSVIIIenv (NL4.3 env)
with either env pNL4.3 or pSV2tat72 is shown below the micrographs. (B) HIV-1 envelope association with DRMs in the presence and absence
of viral proteins other than Tat and Rev. 293T cells were cotransfected with pSVIIIenv which expressed Rev and contained either NL4.3 and HXB2
envelopes together with env pNL4.3, which expresses all viral proteins except for envelope, or pSV2Tat72, which expresses Tat. Cells were lysed
with cold 0.5% Triton X-100 in TNE buffer on ice. Lysates were homogenized, cleared of nuclei, adjusted to 60% sucrose, and applied to the
bottom of a sucrose gradient (as described in Materials and Methods). Gradient fractions were Western blotted and probed for envelope (gp160
and gp41) and Gag (p55) with mouse MAbs. Note that both NL4.3 and HXB2 envelopes associate with DRM fractions in the presence of env
pNL4.3 but were excluded from rafts when expressed in the absence of env pNL4.3 (bottom blots).
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and DRM-H fractions and transferred entirely to the DSM
fractions, following -methyl cyclodextrin treatment (Fig. 5).
These observations are consistent with a specific association of
envelope and DRM-L and do not support a role for buoyant
Gag particles conveying envelope into the lighter fractions of
the sucrose gradient.
A tissue-derived HIV-1 envelope, NA420 LN40, that fails to
incorporate onto virions. An envelope gene that was PCR
amplified from lymph node tissue of an AIDS patient (NA420
LN40) (36) encoded an envelope that was defective for infec-
tivity. LN40 envelope contrasted with a related envelope am-
plified from brain tissue of the same patient (NA420 B33) that
FIG. 2. Effect of a matrix mutation (L30E) on envelope function. (A) 293T cells were transfected with pSVIIIenv (NL4.3 env) with either env
pNL4.3 or env pNL4.3 (L30E) and assessed for envelope expression (left panels) and cell-cell fusion (right panels). (B) Impact of L30E mutation
in p17gag on virus infectivity tested on GHOST/CXCR4 cells and represented as infectivity (FFU) to particle (RT) ratio. (C) Envelope
incorporation into virus particles was assessed by measuring the amounts of envelope in transfected 293T cell supernatants. Virus samples were
precipitated and resuspended in PBS, and equivalent amounts of RT activity were then resolved on a sodium dodecyl sulfate–8% polyacrylamide
gel, followed by Western blotting. Envelope and p24 were probed with Chessie 8 and 183-H12-5C monoclonal antibodies, respectively.
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assembled efficiently onto virions and conferred high infectivity
(36). Nevertheless, NA420 LN40 was efficiently expressed in
293T cells and functional for CCR5-dependent cell-cell fusion
(Fig. 6B). In contrast to NA420 B33, LN40 envelope does not
contain gp41 cytoplasmic-domain cysteine residues that are
targets for palmitoylation and implicated for raft association.
Nevertheless, LN40 envelope carried residues with bulky hy-
drophobic side chains (F764 and Y847) that we previously
showed were sufficient to confer envelope association with
heavy rafts and for nearly wild-type levels of envelope assembly
and infectivity (4). In addition, LN40 envelope had further
changes in sites reported to confer envelope-Gag interactions
(12, 23, 28) (see Discussion). As shown in Fig. 6C and D,
replacement of LN40 gp41 sequences with residues 758 to 856
from B33 sequences (B33758-856) fully restored envelope incor-
poration onto virions and infectivity. This region encompasses
the envelope cytoplasmic region that contains the cysteine res-
idues and sites implicated in Gag interactions (28, 38, 45).
Envelope incorporation onto virions correlates with lipid
raft association. We next tested whether the LN40 wt or LN40
(B33758-856) envelopes could associate with rafts. 293T cells
were transfected with pSVIIIenv encoding each of LN40 wt,
B33 wt, and LN40 (B33758-856) envelopes and pNL4.3 env.
Env 293T cells were lysed in cold Triton X-100 and processed
for sucrose density centrifugation as described above. Frac-
tions were collected and analyzed for the presence of envelope
and Gag. As shown in Fig. 7, p55gag was consistently detected
in all fractions irrespective of envelope mutant constructs.
However, NA420 LN40 wt envelope was found to be excluded
from fractions representing DRMs and detected only in DSM
fractions. Densitometry measurement showed that 96% of
gp160 was present in DSMs. In contrast, B33 and LN40
(B33758-856) both showed abundant envelope association with
DRM-L, with 22.8% and 25.9% of gp160 associated with
DRM-L. These results show a clear correlation between enve-
lope association with DRMs and incorporation onto virions.
DISCUSSION
The existence of lipid rafts on cell membranes has been
controversial. Lipid rafts are usually characterized by ultracen-
trifugation of detergent-lysed cells in sucrose density gradients.
It is possible that this method may affect the structure of cell
membranes in unknown ways and create the phenomenon of
FIG. 3. Effect of matrix mutation on envelope association with lipid
rafts. 293T cells were cotransfected with pSVIIIenv (NL4.3 env) con-
struct and either env pNL4.3 or env pNL4.3 (L30E). Cells were
lysed with cold 0.5% Triton X-100 and homogenized, and postnuclear
supernatants were subjected to sucrose density gradient centrifugation
as described in Materials and Methods. Gradient fractions were sub-
sequently probed for envelope (gp160 and gp41) and Gag (p55) with
mouse MAbs by Western blotting. Note that envelope proteins coex-
pressed with the L30E Gag mutation failed to associate with DRM-L
(bottom panel) compared with that with wild-type Gag (top panel).
FIG. 4. Envelope association with lipid rafts in MOLT 4 T cells.
MOLT 4 cells were infected with VSV-G pseudotype virions pre-
pared with either pNL4.3 wt or pNL4.3 (L30E). After 48 h, cells were
lysed with cold 0.5% Triton X-100 and homogenized, and postnuclear
supernatants were subjected to sucrose density gradient centrifugation
as described in Materials and Methods. Gradient fractions were sub-
sequently probed for envelope (gp160 and gp41) and Gag (p55) with
mouse MAbs by Western blotting. Note that envelope proteins coex-
pressed with the L30E Gag mutation failed to associate with DRM-L
(bottom panel) compared with that with wild-type Gag (top panel).
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rafts (40). Nevertheless, the association of particular mem-
brane proteins with DRMs has physiological relevance. Thus,
putative lipid rafts have been implicated in the traffic and
sorting of membrane proteins throughout the cell, including
the endoplasmic reticulum, Golgi complex, cell membrane,
and vesicles (18, 24). The role of lipid rafts in the trafficking of
HIV-1 envelope to the sites of virus budding is unclear; how-
ever, recent studies have provided evidence that rafts support
budding and assembly of many enveloped viruses, including
HIV-1 (29, 38, 45). Previously, we showed that envelope in-
corporation into lipid rafts conferred optimal assembly onto
virus particles and infectivity (4). In this study, we investigated
whether the Gag precursor was required for envelope associ-
ation with DRMs. Our results show that Gag is required for
HIV-1 envelopes to associate with DRMs. When envelope was
coexpressed with a mutated p55gag (L30E) that does not inter-
act with envelope, then envelope association with DRMs was
eliminated. Several studies have previously supported an inter-
action between Gag and envelope during assembly. Deletions
and mutations in the matrix domain of gag abrogate envelope
incorporation onto mature virions (12, 14–16). In addition,
association of gp41 with p55gag prevents envelope from inter-
acting with endocytic machinery (10). Wyma et al. (44) showed
that in immature HIV-1 particles, the p55gag interaction with
gp41 was shown to be persistent even in the presence of Triton
X-100, suggesting that envelope-Gag interactions are stable in
detergent. In addition, cores isolated from immature HIV-1
virions containing uncleaved p55 precursors partially retain
gp41. Thus, Gag-envelope interactions are intricately involved
in the recruitment of envelope proteins for assembly onto
budding virions.
To further examine the role of the gp41 cytoplasmic domain
in envelope association with lipid rafts, we investigated a pa-
tient-derived envelope (NA420 LN40) that was found to be
defective for envelope incorporation onto virions. The NA420
LN40 envelope was derived by PCR from lymph node tissue of
an AIDS patient (36). Sequence analyses revealed that LN40
envelope gp41 has several amino acid changes compared to
B33, a functional envelope encoded by sequences amplified
from brain tissue of the same patient. The amino acid sub-
stitutions included (i) C764F that eliminates the single (pal-
mitoylation targeted) cysteine residue from the gp41 cytoplasmic
region of this envelope and (ii) RR and HS substitutions at
positions 787 and 788, respectively. These latter substitutions
are located in the LLP-2 domain of gp41, a region previously
FIG. 5. Effect of -methyl cyclodextrin on envelope and Gag asso-
ciation with lipid rafts. Untransfected 293T cells were treated with and
without 10 mM -methyl cyclodextrin (MCD) and subsequently lysed
with cold Triton X-100. Postnuclear supernatants were resolved by
sucrose density centrifugation, and DRM and DSM fractions were
analyzed for the presence of caveolin by Western blotting. The effect
of -methyl cyclodextrin on p55gag and envelope was tested on 293T
cells cotransfected with pSVIIIenv and env pNL4.3.
FIG. 6. Functionality, infectivity, and assembly of patient-derived
NA420 envelopes. (A) Amino acids from position 758 to the C terminus
(position 856) of NA420 B33 gp41 cytoplasmic domain were introduced
into LN40 to produce the NA420 LN40 (B33758-856) chimeric construct.
(B) Functionality of LN40, B33, and NA420 LN40 (B33758-856) was as-
sessed by cell-cell fusion. (C) Envelope incorporation was measured by
resolving virus pellets on SDS-polyacrylamide gels, followed by Western
blotting. (D) Infectivity conferred by each of the patient-derived enve-
lopes was measured in GHOST/CCR5 cells and plotted as infectivity
(FFU) to particle (RT) ratios.
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implicated in envelope-Gag interactions and assembly onto
virus particles (12, 21). LN40 envelope failed to associate with
DRMs, even in the presence of Gag, thus firmly implicating the
importance of this envelope region for assembly.
The envelope must traffic from the site of synthesis in the
endoplasmic reticulum to sites of virus budding. However, the
roles of envelope-Gag interactions and lipid raft association in
this process are unknown. Neither is it known where Gag and
envelope interact, whether at the sites of virus budding or
during envelope traffic. Nor it is known if the envelope-Gag
interaction is required for envelope trafficking before associa-
tion with lipid rafts. The site of envelope palmitoylation is also
unclear, and it will be interesting to test whether envelope
excluded from rafts is palmitoylated. We cannot rule out
whether H787/S788 or other LN40 mutations might interfere
with envelope trafficking to a site in the cell where it meets
Gag. Interestingly, substitution of F764C in the gp41 cytoplas-
mic domain of LN40 envelope did not rescue the envelope
incorporation and infectivity nor facilitate envelope associa-
tion with rafts in the presence of H787 and S788 (not shown).
These observations are consistent with our previous conclu-
sions that gp41 cysteines are neither sufficient nor entirely
essential for envelope association with DRMs and assembly
onto virions.
Our observations show that HIV-1 Gag is required for en-
velope glycoproteins to associate with DRMs. In contrast, the
reciprocal arrangement has been reported for other viruses.
Thus, for respiratory syncytial virus, the association of the
matrix protein with DRMs is dependent on the expression of
envelope glycoproteins (19). Similarly, influenza virus matrix
protein associated with DRMs only if hemagglutinin and neur-
aminidase glycoproteins were coexpressed (1).
In conclusion, we have demonstrated that the p55gag protein
is required to recruit envelope into DRMs. Identification of
critical motifs regulating envelope trafficking and assembly
onto virions will help the design of strategies to prevent release
of infectious virions.
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